OAM
FLGT icon

Oxford Asset Management’s Fulgent Genetics FLGT Stock Holding History

Oxford Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,673
Closed -$254K – 579
2025
Q4 		$254K Buy
+9,673
New +$251K 0.09% 339

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Oxford Asset Management's FLGT Position: Q1 2026 in Review

Oxford Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 9,673 shares — an estimated $254K sold.

Oxford Asset Management first reported a position in FLGT in Q4 2025 and held it in 1 quarter. The position peaked at $254K in Q4 2025. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Oxford Asset Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Oxford Asset Management sold 9,673 Fulgent Genetics shares in Q1 2026, an estimated $254K.
  • Oxford Asset Management first reported a position in Fulgent Genetics in Q4 2025 and held it in 1 quarter.
  • Oxford Asset Management's Fulgent Genetics position peaked at $254K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.